Katharina Erlenbach‐Wünsch

Author

Universitätsklinikum Erlangen

Also Known As

K. Erlenbach-Wünsch, Katharina Erlenbach-Wünsch, Katharina Erlenbach‐Wünsch

Publications

440

Citations

H-Index

Concepts

All Affiliations

Universitätsklinikum Erlangen Friedrich-Alexander-Universität Erlangen-Nürnberg Bayreuth Medical Center University of Bern

About

Katharina Erlenbach‐Wünsch is an author at Universitätsklinikum Erlangen specializing in medicine, pathology, and oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	7	7	340
2	Cell Biology	2	2	141
3	Gastroenterology	2	2	39
4	Health Sciences	1	1	10
5	Immunology	1	1	23

Katharina Erlenbach‐Wünsch

Publications

434

Citations

H-Index

Page 1

	Year	Citations
ISL1 expression is not restricted to pancreatic well-differentiated neuroendocrine neoplasms, but is also commonly found in well and poorly differentiated neuroendocrine neoplasms of extrapancreatic origin Abbas Agaimy, Katharina Erlenbach‐Wünsch, Björn Konukiewitz, Modern Pathology Neuroendocrine NeoplasmsPancreatic CancerPathologyPancreatic SurgerySecretory Granules	2013	125
PD-L1 is upregulated by radiochemotherapy in rectal adenocarcinoma patients and associated with a favourable prognosis Markus Hecht, Maike Büttner‐Herold, Katharina Erlenbach‐Wünsch, European Journal of Cancer MedicineCancer GrowthPathologyImmune Checkpoint InhibitorFavourable Prognosis	2016	125
Loss of enhancer of zeste homologue 2 (EZH2) at tumor invasion front is correlated with higher aggressiveness in colorectal cancer cells J. Böhm, Julienne K. Muenzner, Aylin Caliskan, Journal of Cancer Research and Clinical Oncology	2019	38
Spatial distribution of FoxP3+ and CD8+ tumour infiltrating T cells reflects their functional activity Rebecca Posselt, Katharina Erlenbach‐Wünsch, Matthias Haas, Oncotarget	2016	37
Comprehensive screening for mutations associated with colorectal cancer in unselected cases reveals penetrant and nonpenetrant mutations Cornelia Kraus, Tilman T. Rau, Philipp Lux, International Journal of Cancer Consecutive Crc PatientsSomatic VariantNonpenetrant MutationsTumor HeterogeneityMedicine	2014	25
Inflammatory response in serrated precursor lesions of the colon classified according to WHO entities, clinical parameters and phenotype–genotype correlation Tilman T. Rau, Raja Atreya, Daniela E. Aust, The Journal of Pathology Clinical Research ImmunologyGastroenterologyPathologyClassical AdenomasWho Entities	2016	23
Regulatory T cells and cytotoxic T cells close to the epithelial–stromal interface are associated with a favorable prognosis Julian Rudolf, Maike Büttner‐Herold, Katharina Erlenbach‐Wünsch, OncoImmunology	2020	19
Expression of the LIM homeobox domain transcription factor ISL1 (Islet-1) is frequent in rhabdomyosarcoma but very limited in other soft tissue sarcoma types Katharina Erlenbach‐Wünsch, Florian Haller, Helge Täubert, Pathology MedicinePathologyCancer GeneticsGene ExpressionCancer Biology	2014	16
Serrated epithelial colorectal polyps (hyperplastic polyps, sessile serrated adenomas) with perineurial stroma: Clinicopathological and molecular analysis of a new series Katharina Erlenbach‐Wünsch, Michel Bihl, Arndt Hartmann, Annals of Diagnostic Pathology UrologyGastroenterologyPathologyNew SeriesPerineurial Stroma	2018	16
ypN0 nodal status after neoadjuvant chemoradiotherapy for rectal carcinoma is not associated with adverse prognosis as compared with pN0 after primary surgery Katharina Erlenbach‐Wünsch, Sabine Semrau, Rainer Fietkau, International Journal of Colorectal Disease Surgical OncologyHealth SciencesRadiation TherapyGastrointestinal OncologyMedicine	2013	10

Page 1